drugset

drugset / Trial / NCT00234988

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

NCT00234988 ↗

Phase 4 Completed 93 enrolled Abbott

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.

Timeline

Start: 2004-06
Primary completion: 2006-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sibutramine	Small molecule	15 mg	—

Indications